Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2017 · limited partnership

$1.3bn reported value -2.3% vs Q1 2024
72positions
61.2%in top 10
16 new 25 added 27 reduced 12 sold out vs Q1 2024

Options: 0 call positions (— notional), 2 put positions ($153.6m notional) – listed below, not included above.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GSK PLC SPONSORED ADR GSK GSK 3,468,080 $133.5m10.22% 10.22% ReducedShares held: Q3 2023 3.3m, Q4 2023 3.0m, Q1 2024 3.8m, Q2 2024 3.5m -303.9k -303,914 -8.1%
2 NATERA INC COM NTRA NTRA 1,173,494 $127.1m9.73% 9.73% ReducedShares held: Q3 2023 2.5m, Q4 2023 2.3m, Q1 2024 1.8m, Q2 2024 1.2m -604.6k -604,557 -34.0%
3 INSMED INC COM PAR $.01 INSM INSM 1,155,588 $77.4m5.93% 5.93% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.2m
4 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 4,720,460 $76.7m5.87% 5.87% ReducedShares held: Q3 2023 7.0m, Q4 2023 6.2m, Q1 2024 6.0m, Q2 2024 4.7m -1.3m -1,304,709 -21.6%
5 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 235,351 $75.0m5.74% 5.74% ReducedShares held: Q3 2023 267.9k, Q4 2023 246.2k, Q1 2024 251.1k, Q2 2024 235.4k -15.8k -15,784 -6.3%
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,613,631 $74.2m5.68% 5.68% AddedShares held: Q3 2023 2.6m, Q4 2023 3.4m, Q1 2024 3.1m, Q2 2024 3.6m +480.5k +480,518 15.3%
7 VERA THERAPEUTICS INC CL A VERA VERA 2,043,214 $73.9m5.66% 5.66% AddedShares held: Q3 2023 1.5m, Q4 2023 1.9m, Q1 2024 1.8m, Q2 2024 2.0m +219.4k +219,433 12.0%
8 INSPIRE MED SYS INC COM INSP INSP 533,011 $71.3m5.46% 5.46% AddedShares held: Q3 2023 193.0k, Q4 2023 351.1k, Q1 2024 420.7k, Q2 2024 533.0k +112.3k +112,312 26.7%
9 REVVITY INC COM RVTY RVTY 451,582 $47.4m3.62% 3.62% ReducedShares held: Q3 2023 32.7k, Q4 2023 183.1k, Q1 2024 483.2k, Q2 2024 451.6k -31.6k -31,578 -6.5%
10 HCA HEALTHCARE INC COM HCA HCA 135,480 $43.5m3.33% 3.33% AddedShares held: Q3 2023 110.1k, Q4 2023 114.8k, Q1 2024 103.8k, Q2 2024 135.5k +31.7k +31,659 30.5%
11 BIO-TECHNE CORP COM TECH TECH 543,044 $38.9m2.98% 2.98% ReducedShares held: Q3 2023 385.9k, Q4 2023 465.3k, Q1 2024 607.7k, Q2 2024 543.0k -64.6k -64,643 -10.6%
12 HEALTHEQUITY INC COM HQY HQY 413,531 $35.6m2.73% 2.73% ReducedShares held: Q3 2023 338.5k, Q4 2023 494.9k, Q1 2024 421.3k, Q2 2024 413.5k -7.8k -7,814 -1.9%
13 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 8,037,470 $27.0m2.07% 2.07% AddedShares held: Q3 2023 7.1m, Q4 2023 7.2m, Q1 2024 8.0m, Q2 2024 8.0m +56.8k +56,829 0.7%
14 REPLIGEN CORP COM RGEN RGEN 194,291 $24.5m1.87% 1.87% AddedShares held: Q3 2023 16.2k, Q4 2023 10.0k, Q1 2024 8.2k, Q2 2024 194.3k +186.1k +186,054 2258.8%
15 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 633,015 $23.4m1.79% 1.79% ReducedShares held: Q3 2023 588.1k, Q4 2023 754.1k, Q1 2024 711.1k, Q2 2024 633.0k -78.1k -78,100 -11.0%
16 IONIS PHARMACEUTICALS INC COM IONS IONS 456,881 $21.8m1.67% 1.67% AddedShares held: Q3 2023 252.4k, Q4 2023 324.7k, Q1 2024 376.4k, Q2 2024 456.9k +80.4k +80,443 21.4%
17 NOVO-NORDISK A S ADR NVO NVO 146,956 $21.0m1.61% 1.61% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 62.3k, Q2 2024 147.0k +84.6k +84,612 135.7%
18 ELI LILLY & CO COM LLY LLY 21,233 $19.2m1.47% 1.47% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 12.9k, Q2 2024 21.2k +8.4k +8,356 64.9%
19 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 505,836 $17.5m1.34% 1.34% AddedShares held: Q3 2023 286.7k, Q4 2023 538.1k, Q1 2024 411.5k, Q2 2024 505.8k +94.4k +94,358 22.9%
20 ARGENX SE SPONSORED ADR ARGX ARGX 34,593 $14.9m1.14% 1.14% ReducedShares held: Q3 2023 4.6k, Q4 2023 85.8k, Q1 2024 54.5k, Q2 2024 34.6k -19.9k -19,925 -36.5%
21 HUMANA INC COM HUM HUM 38,023 $14.2m1.09% 1.09% AddedShares held: Q3 2023 18.1k, Q4 2023 1.9k, Q1 2024 35.5k, Q2 2024 38.0k +2.5k +2,491 7.0%
22 VIATRIS INC COM VTRS VTRS 1,329,282 $14.1m1.08% 1.08% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.3m, Q2 2024 1.3m +12.8k +12,813 1.0%
23 ZIMVIE INC COM ZIMV ZIMV 767,659 $14.0m1.07% 1.07% AddedShares held: Q3 2023 0, Q4 2023 546.4k, Q1 2024 564.5k, Q2 2024 767.7k +203.2k +203,161 36.0%
24 MANNKIND CORP COM NEW MNKD MNKD 2,256,952 $11.8m0.90% 0.90% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.4m, Q2 2024 2.3m -134.2k -134,176 -5.6%
25 BROOKDALE SR LIVING INC COM BKD BKD 1,546,842 $10.6m0.81% 0.81% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.3m, Q2 2024 1.5m +228.1k +228,077 17.3%
26 DANAHER CORPORATION COM DHR DHR 40,855 $10.2m0.78% 0.78% UnchangedShares held: Q3 2023 103.8k, Q4 2023 41.0k, Q1 2024 40.9k, Q2 2024 40.9k
27 SPDR SER TR S&P BIOTECH XBI XBI 100,000 $9.3m0.71% 0.71% NewShares held: Q3 2023 20.0k, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
28 TRAVERE THERAPEUTICS INC COM TVTX TVTX 1,091,165 $9.0m0.69% 0.69% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 955.6k, Q2 2024 1.1m +135.5k +135,547 14.2%
29 ELEVANCE HEALTH INC COM ELV ELV 14,657 $7.9m0.61% 0.61% AddedShares held: Q3 2023 21.7k, Q4 2023 15.1k, Q1 2024 14.4k, Q2 2024 14.7k +264 +264 1.8%
30 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 837,847 $7.8m0.60% 0.60% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 837.8k
31 CENTENE CORP DEL COM CNC CNC 115,820 $7.7m0.59% 0.59% AddedShares held: Q3 2023 190.6k, Q4 2023 97.2k, Q1 2024 92.8k, Q2 2024 115.8k +23.0k +23,034 24.8%
32 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 567,487 $7.4m0.57% 0.57% AddedShares held: Q3 2023 443.3k, Q4 2023 137.3k, Q1 2024 142.1k, Q2 2024 567.5k +425.4k +425,412 299.4%
33 VIKING THERAPEUTICS INC COM VKTX VKTX 138,489 $7.3m0.56% 0.56% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 22.8k, Q2 2024 138.5k +115.7k +115,671 506.9%
34 VAXCYTE INC COM PCVX PCVX 96,089 $7.3m0.56% 0.56% ReducedShares held: Q3 2023 190.4k, Q4 2023 233.8k, Q1 2024 197.3k, Q2 2024 96.1k -101.2k -101,242 -51.3%
35 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 1,152,573 $7.1m0.55% 0.55% ReducedShares held: Q3 2023 2.5m, Q4 2023 1.5m, Q1 2024 1.4m, Q2 2024 1.2m -279.9k -279,854 -19.5%
36 CYTOKINETICS INC COM NEW CYTK CYTK 126,877 $6.9m0.53% 0.53% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 126.9k
37 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 329,890 $6.3m0.48% 0.48% ReducedShares held: Q3 2023 660.6k, Q4 2023 374.4k, Q1 2024 354.0k, Q2 2024 329.9k -24.1k -24,075 -6.8%
38 EVOLUS INC COM EOLS EOLS 574,462 $6.2m0.48% 0.48% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 574.5k
39 MOLINA HEALTHCARE INC COM MOH MOH 18,277 $5.4m0.42% 0.42% AddedShares held: Q3 2023 12.2k, Q4 2023 6.1k, Q1 2024 5.8k, Q2 2024 18.3k +12.4k +12,449 213.6%
40 SUTRO BIOPHARMA INC COM COM 1,739,129 $5.1m0.39% 0.39% AddedShares held: Q3 2023 769.6k, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 1.7m +647.7k +647,710 59.4%
41 GOSSAMER BIO INC COM GOSS GOSS 5,484,148 $4.9m0.38% 0.38% ReducedShares held: Q3 2023 4.4m, Q4 2023 6.4m, Q1 2024 6.0m, Q2 2024 5.5m -510.3k -510,324 -8.5%
42 OSCAR HEALTH INC CL A OSCR OSCR 310,893 $4.9m0.38% 0.38% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 310.9k
43 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 110,010 $4.5m0.34% 0.34% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 110.0k
44 LIQUIDIA CORPORATION COM NEW LQDA LQDA 373,554 $4.5m0.34% 0.34% ReducedShares held: Q3 2023 1.4m, Q4 2023 688.9k, Q1 2024 396.2k, Q2 2024 373.6k -22.6k -22,633 -5.7%
45 MYRIAD GENETICS INC COM MYGN MYGN 181,961 $4.5m0.34% 0.34% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 182.0k
46 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,328,454 $4.3m0.33% 0.33% ReducedShares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.4m, Q2 2024 1.3m -98.0k -98,043 -6.9%
47 KARYOPHARM THERAPEUTICS INC COM COM 4,987,180 $4.3m0.33% 0.33% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 5.0m, Q2 2024 5.0m -29.1k -29,140 -0.6%
48 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 1,107,743 $4.3m0.33% 0.33% ReducedShares held: Q3 2023 1.5m, Q4 2023 1.1m, Q1 2024 1.2m, Q2 2024 1.1m -69.9k -69,935 -5.9%
49 NEVRO CORP COM NVRO NVRO 499,395 $4.2m0.32% 0.32% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 389.7k, Q2 2024 499.4k +109.7k +109,732 28.2%
50 ICON PLC SHS ICLR ICLR 12,642 $4.0m0.30% 0.30% ReducedShares held: Q3 2023 21.0k, Q4 2023 15.4k, Q1 2024 15.3k, Q2 2024 12.6k -2.7k -2,705 -17.6%
51 MERUS N V COM MRUS MRUS 66,474 $3.9m0.30% 0.30% ReducedShares held: Q3 2023 134.0k, Q4 2023 115.7k, Q1 2024 119.5k, Q2 2024 66.5k -53.0k -53,008 -44.4%
52 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 71,596 $3.1m0.24% 0.24% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 71.6k
53 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 4,308,527 $3.0m0.23% 0.23% ReducedShares held: Q3 2023 8.4m, Q4 2023 6.1m, Q1 2024 6.2m, Q2 2024 4.3m -1.9m -1,904,221 -30.6%
54 GUARDANT HEALTH INC COM GH GH 99,377 $2.9m0.22% 0.22% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 449.6k, Q2 2024 99.4k -350.2k -350,209 -77.9%
55 INFLARX NV COM IFRX IFRX 1,566,930 $2.7m0.21% 0.21% AddedShares held: Q3 2023 1.7m, Q4 2023 1.3m, Q1 2024 1.3m, Q2 2024 1.6m +261.8k +261,790 20.1%
56 AVANTOR INC COM AVTR AVTR 125,394 $2.7m0.20% 0.20% UnchangedShares held: Q3 2023 84.5k, Q4 2023 126.0k, Q1 2024 125.4k, Q2 2024 125.4k
57 TOURMALINE BIO INC COM TRML TRML 204,781 $2.6m0.20% 0.20% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 204.8k
58 IQVIA HLDGS INC COM IQV IQV 12,178 $2.6m0.20% 0.20% UnchangedShares held: Q3 2023 23.0k, Q4 2023 12.3k, Q1 2024 12.2k, Q2 2024 12.2k
59 ALECTOR INC COM ALEC ALEC 541,739 $2.5m0.19% 0.19% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 536.2k, Q2 2024 541.7k +5.6k +5,568 1.0%
60 IMMUNOVANT INC COM IMVT IMVT 92,909 $2.5m0.19% 0.19% ReducedShares held: Q3 2023 0, Q4 2023 113.8k, Q1 2024 255.5k, Q2 2024 92.9k -162.6k -162,617 -63.6%
61 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 91,907 $2.2m0.17% 0.17% ReducedShares held: Q3 2023 90.0k, Q4 2023 93.7k, Q1 2024 97.1k, Q2 2024 91.9k -5.2k -5,158 -5.3%
62 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 610,902 $2.1m0.16% 0.16% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 610.9k
63 TERNS PHARMACEUTICALS INC COM COM 286,266 $1.9m0.15% 0.15% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 283.0k, Q2 2024 286.3k +3.2k +3,232 1.1%
64 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 496,171 $1.8m0.14% 0.14% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 496.2k
65 KURA ONCOLOGY INC COM KURA KURA 72,317 $1.5m0.11% 0.11% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 72.3k
66 ABSCI CORPORATION COM ABSI ABSI 325,509 $1.0m0.08% 0.08% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 325.5k
67 FULCRUM THERAPEUTICS INC COM FULC FULC 152,965 $948.4k0.07% 0.07% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 153.0k
68 AFFIMED N V ORDINARY SHS NEW AFMDQ AFMDQ 166,460 $907.2k0.07% 0.07% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 166.5k, Q2 2024 166.5k
69 STOKE THERAPEUTICS INC COM STOK STOK 61,277 $827.9k0.06% 0.06% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 290.0k, Q2 2024 61.3k -228.7k -228,723 -78.9%
70 G1 THERAPEUTICS INC COM GTHX GTHX 199,963 $455.9k0.03% 0.03% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 200.0k
71 AC IMMUNE SA SHS ACIU ACIU 99,313 $396.3k0.03% 0.03% ReducedShares held: Q3 2023 124.6k, Q4 2023 124.6k, Q1 2024 124.6k, Q2 2024 99.3k -25.3k -25,276 -20.3%
72 SERES THERAPEUTICS INC COM COM 418,208 $302.7k0.02% 0.02% ReducedShares held: Q3 2023 2.4m, Q4 2023 1.8m, Q1 2024 1.4m, Q2 2024 418.2k -970.7k -970,736 -69.9%

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
PFIZER INC PFE PFE 1,102,042 $30.6m1.1m shares
SHOCKWAVE MED INC SWAV SWAV 80,555 $26.2m80.6k shares
TENET HEALTHCARE CORP THC THC 175,631 $18.5m175.6k shares
TARO PHARMACEUTICAL INDS LTD TARO TARO 263,541 $11.2m263.5k shares
TAYSHA GENE THERAPIES INC TSHA TSHA 2,325,591 $6.7m2.3m shares
WATERS CORP WAT WAT 13,628 $4.7m13.6k shares
CORBUS PHARMACEUTICALS HLDGS CRBP CRBP 88,934 $3.5m88.9k shares
KRYSTAL BIOTECH INC KRYS KRYS 18,557 $3.3m18.6k shares
MORPHOSYS AG 165,924 $3.0m165.9k shares
AEROVATE THERAPEUTICS INC 54,150 $1.6m54.1k shares
CUREVAC N V CVAC CVAC 515,691 $1.6m515.7k shares
VINCERX PHARMA INC 79,588 $402.7k79.6k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 285,600 $136.8m285.6k shares Reduced
SPDR S&P 500 ETF TR SPY · Put SPYPut 30,800 $16.8m30.8k shares Added

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17